FdaApplication
NDA 021697
Identifiers
- fda_app_no: NDA021697
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | NDA |
| approval_date | 2005-12-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VAPRISOL | CONIVAPTAN HYDROCHLORIDE | 20MG/4ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
| VAPRISOL IN 5% DEXTROSE IN PLASTIC CONTAINER | CONIVAPTAN HYDROCHLORIDE | 20MG/100ML (0.2MG/ML) | INJECTABLE;INTRAVENOUS |
2 products